caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1588626055

NPI 1588626055

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where NPI 1588626055's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 34 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
LEDERMAN, CARL80180
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
63186
Frank Groshek
Diagnostic Radiology · Annapolis, MD
50102
Vani Padmanabha
Pathology · Washington, DC
49115
Khosrow Davachi
Internal Medicine · Clinton, MD
28113
Norman Allen
Cardiology · Washington, DC
2762
Mark Major
Family Practice · Silver Spring, MD
26104
Mohammad Ghandi
Internal Medicine · Washington, DC
2570
MASIH, TALIB2346
Julian Craig
Internal Medicine · Washington, DC
2283
Mowaffak Alhamad
Thoracic Surgery · Washington, DC
2242
BOVBEL, ALEXANDRA2163
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.